Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference and Safety of Sugamet XR in T2DM with Renal Disease
NCT04653779Phase 4Unknown
- Sponsor
- Dong-A ST
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of DA5221-B2 in type 2 diabetes mellitus (T2DM), sponsored by Dong-A ST. Status: unknown.
02
Drugs
DA5221-B2
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04653779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04653779.